Parse

Parse indexes AI recommendations so brands know where they stand.

Products

  • Brands
  • Markets
  • Integrations
  • Work with us
  • Pricing
  • MCP

Resources

  • Research
  • Methodology
  • Blog

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Work with usPricing
Sign inCheck your brand
  1. Brands
  2. Mounjaro
BrandsMounjaro

How AI describes Mounjaro

Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this

Mounjaro logoMounjaromounjaro.lilly.com

Mounjaro (tirzepatide) is an injectable prescription medicine used with diet and exercise to improve blood sugar in adults and children aged 10 and older with type 2 diabetes. In studies, 75% to 90% of adults taking Mounjaro reached an A1C of less than 7%, with weight loss ranging from 12 to 25 pounds.

Ownership
Part ofEli Lilly and Company logoEli Lilly and Company
Mounjaro logoMounjaro

Parse Score

66.7
Strength74
Reach52
Authority18

Work at Mounjaro?

Claim this profile for the full report: every prompt where Mounjaro appears, who is gaining, and what AI says about you. Claiming is free and unlocks your brand’s ambient view. Monitoring a market is the paid layer on top.

Verified with a work email.

Track this weekly.

Monitor Mounjaro

AI questions where Mounjaro appears

Prompt
Prompt visibility
What's the best digital therapeutic for managing type 2 diabetes?0.9

Always know where you stand in AI

Start monitoring Mounjaro